Conclusions: Human papillomavirus (HPV) cervical infections are highly
prevalent among females under 21 years, yet this age group has a low incidence
of cervical cancer. For young women, 90% of HPV infections regress in
24 months, and, in longitudinal studies, no invasive cervical cancer was detected.
HPV co-testing is effective for women age 30 and over